Atlas Trials

Atovaquone as Tumour HypOxia Modifier

Clinical trial NCT02628080 · COMPLETED

Trial details

NCT number
NCT02628080
Sponsor
University of Oxford
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2016-05-01
Primary completion
2018-10-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.